Spire Wealth Management’s Vaxart VXRT Stock Holding History

Spire Wealth Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$2K	–	2986
2021 Q1	$2K	Buy	+300	New	+$2.31K	﹤0.01%	2895

Other funds holding VXRT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Spire Wealth Management's VXRT Position: Q2 2021 in Review

Spire Wealth Management sold out of Vaxart (VXRT) in Q2 2021, closing a stake of 300 shares — an estimated $2K sold.

Spire Wealth Management first reported a position in VXRT in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 143 funds tracked by Wall St. Rank hold VXRT as of Q2 2021.

Spire Wealth Management reported no remaining Vaxart position as of Q2 2021 after selling out during the quarter.
Spire Wealth Management sold 300 Vaxart shares in Q2 2021, an estimated $2K.
Spire Wealth Management first reported a position in Vaxart in Q1 2021 and held it in 1 quarter.
Spire Wealth Management's Vaxart position peaked at $2K in Q1 2021.
143 funds tracked by Wall St. Rank held Vaxart as of Q2 2021.

Based on Spire Wealth Management's 13F filing for Q2 2021, filed 26 Jul 2021.